Analytical Methods Validation for FDA Compliance Drugs and Biologics: From Lab to Lab - Learn Crucial Techniques for Transferring Analytical Procedures (ONLINE EVENT: December 16-18, 2024/ON-DEMAND)
December 04, 2024 04:58 ET
|
Research and Markets
Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The "Analytical Methods Validation for FDA Compliance Drugs and Biologics" training has been added to ResearchAndMarkets.com's offering. Dependable...
Biopharmaceuticals Manufacturing Consumables Industry Research Report 2024-2030: Growing Demand for API Testing Fueling Growth, Shift Toward Large Biological Molecules Driving Demand
November 19, 2024 12:02 ET
|
Research and Markets
Dublin, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals Manufacturing Consumables Testing Market Size, Share and Trends Analysis Report by Service (Laboratory, Custom), Raw Material...
Lifecore Biomedical to Present at Stephens Annual Investment Conference
November 12, 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
FDA Process Validation for Pharmaceutical and Biologics - 2 Day Online Training Course, October 22-23, 2024
September 27, 2024 04:04 ET
|
Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Process Validation for Pharmaceutical and Biologics" training has been added to ResearchAndMarkets.com's offering. This FDA Process Validation...
Orphan Drugs Market Size & Share to Surpass USD 424.0 billion by 2034, Rising a CAGR 6.9% | Analysis by Transparency Market Research, Inc.
September 26, 2024 07:14 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The orphan drugs market (희귀의약품 시장) was worth US$ 195.0 billion in 2023. The market is...
IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2024: Humanized, Fully Human, Chimeric, Other Sources Insights and Forecasts 2019-2023 & 2024-2029
September 23, 2024 07:07 ET
|
Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other...
Biopharmaceuticals Global Business Report 2024 with Focus on 200+ Select Players Including Abbott, Amgen, Biogen, Eli Lilly and Co, F. Hoffmann-La Roche, J&J, Merck, Novo Nordisk, Pfizer, Sanofi
August 23, 2024 07:20 ET
|
Research and Markets
Dublin, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Rare Kidney Diseases Market Report 2024 to 2035, by Target Indications, Type of Molecule, Route of Administration and Key Geographies
August 13, 2024 07:11 ET
|
Research and Markets
Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The "Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications, Type of Molecule, Type of...
Global Biologics Contract Development and Manufacturing Organizations Market Report 2024-2029: End-to-end mRNA Services & Expanding Drug Capabilities to Support Anti-obesity Drugs Fuels Opportunities
July 31, 2024 09:41 ET
|
Research and Markets
Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024-2029" report has been added to ResearchAndMarkets.com's...
Europe Biologics CDMO Market Research 2023-2032: Companies that Skillfully Navigate Regulatory Complexities and Adopt Technological Innovations are Well-Positioned for Significant Success
July 01, 2024 05:09 ET
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Europe Biologics CDMO Market: Focus on Cell Type, Molecule Type, and Country - Analysis and Forecast, 2023-2032" report has been added to ...